BridgeMD
New treatment option for HIV
Official title Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria
ClinicalTrials.gov ID: NCT06190613
What this study is testing
- What it's testing
- The study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve HIV treatment engagement, medication adherence and viral suppression among YMSM and YTW, ages 15-29.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 29, men only
You may be able to join if
- HIV seropositive
- registered as a patient at one of the collaborating key population (KP)-focused community centers
- male sex at birth
- identify as YMSM or YTW (or report a history of sex with men)
- on ART for at least 3 months
You likely can't join if
- Unable to obtain parental permission if 15 years of age and not emancipated
See the full eligibility criteria
- HIV seropositive
- registered as a patient at one of the collaborating key population (KP)-focused community centers
- male sex at birth
- identify as YMSM or YTW (or report a history of sex with men)
- on ART for at least 3 months
- understand and read basic English, Yoruba, or Pidgin English
- intention to remain a patient at a collaborating clinic during the 24-week follow-up period
- has a cellphone
- Unable to obtain parental permission if 15 years of age and not emancipated
The study team makes the final eligibility decision.
Where it's taking place
- Ibadan, Nigeria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 15 years to 29 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ibadan, Nigeria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.